Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 study of COVID-2019 vaccine

Next Previous
X
Search
Trial Profile

A Phase 1 study of COVID-2019 vaccine

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 11 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs COVID-2019 vaccine-Ufovax (Primary)
  • Indications COVID 2019 infections
  • Focus Adverse reactions; First in man

    • Most Recent Events

    • 03 Nov 2021 According to an Ufovax media release, the company expects to start this study in the first half of 2022.
    • 07 Sep 2020 New trial record
    • 25 Aug 2020 According to an Ufovax media release, the company expect to file IND application in Q4 2020 and initiate this study by the end of 2020 or in early 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top